CONMED Corp — Director's Dealing 2024

Nov 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2024-11-07

Reporting Person: Hartman Curt R (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-07	Common Stock	M	30000	$51.30	Acquired	34299	Direct
2024-11-07	Common Stock	F	24303	$74.76	Disposed	9996	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-07	SARs (Stock Appreciation Rights)	$51.30	M	30000	Disposed	2025-02-27	Common Stock (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	83500	Indirect

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (20%) over a five year period.